His primary areas of study are Microbiology, Broth microdilution, Antimicrobial, Antibacterial agent and Staphylococcus aureus. Microbiology is represented through his Meropenem, Acinetobacter, Antibiotic resistance, Imipenem and Sentry research. His Meropenem study combines topics from a wide range of disciplines, such as Ceftazidime, Klebsiella pneumoniae and Tazobactam.
While the research belongs to areas of Broth microdilution, Helio S. Sader spends his time largely on the problem of Cephalosporin, intersecting his research to questions surrounding Ceftaroline fosamil. Helio S. Sader has researched Antimicrobial in several fields, including Polymyxin B and Drug resistance. His Antibacterial agent research includes elements of Gram-Positive Cocci and Potency.
His primary areas of investigation include Microbiology, Broth microdilution, Antimicrobial, Staphylococcus aureus and Antibacterial agent. His studies in Microbiology integrate themes in fields like Vancomycin, Daptomycin and Linezolid. The concepts of his Broth microdilution study are interwoven with issues in Acinetobacter, Pseudomonas aeruginosa, Ceftazidime, Cephalosporin and Klebsiella pneumoniae.
His Antimicrobial research incorporates elements of Antibiotic resistance, Drug resistance and Intensive care medicine. Antibacterial agent is a subfield of Antibiotics that Helio S. Sader explores. His work carried out in the field of Meropenem brings together such families of science as Piperacillin, Tazobactam, Imipenem, Amikacin and Colistin.
Helio S. Sader focuses on Microbiology, Antimicrobial, Broth microdilution, Staphylococcus aureus and Ceftazidime/avibactam. Helio S. Sader works in the field of Microbiology, focusing on Meropenem in particular. In his study, Ceftolozane and Aztreonam is strongly linked to Avibactam, which falls under the umbrella field of Antimicrobial.
His Broth microdilution research includes themes of Colistin, Levofloxacin, Veterinary medicine, Cephalosporin and Antibiotic resistance. Helio S. Sader works mostly in the field of Staphylococcus aureus, limiting it down to topics relating to Streptococcus pneumoniae and, in certain cases, Penicillin and Tigecycline. His study in Ceftazidime/avibactam is interdisciplinary in nature, drawing from both Piperacillin/tazobactam, Enterobacter cloacae and Internal medicine.
His scientific interests lie mostly in Microbiology, Broth microdilution, Antimicrobial, Enterobacteriaceae and Staphylococcus aureus. The study incorporates disciplines such as Pseudomonas aeruginosa and Klebsiella pneumoniae in addition to Microbiology. His work deals with themes such as Pneumonia, Ceftazidime, Cefepime, Acinetobacter and Meropenem, which intersect with Broth microdilution.
The Antimicrobial study combines topics in areas such as Avibactam, Antibiotic resistance, Multiple drug resistance and Bacterial pneumonia. His work on Enterococcus faecalis and Daptomycin as part of general Staphylococcus aureus study is frequently connected to Food and drug administration, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His studies deal with areas such as Enterococcus faecium and Linezolid, Vancomycin, Dalbavancin, Ceftobiprole as well as Enterococcus faecalis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.
M. A. Pfaller;D. J. Diekema;R. N. Jones;H. S. Sader.
Journal of Clinical Microbiology (2001)
Emerging Importance of Multidrug-Resistant Acinetobacter Species and Stenotrophomonas maltophilia as Pathogens in Seriously Ill Patients: Geographic Patterns, Epidemiological Features, and Trends in the SENTRY Antimicrobial Surveillance Program (1997–1999)
Ana Cristina Gales;Ana Cristina Gales;R. N. Jones;K. R. Forward;J. Linares.
Clinical Infectious Diseases (2001)
International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program
M. A. Pfaller;R. N. Jones;G. V. Doern;H. S. Sader.
Journal of Clinical Microbiology (1998)
International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents
M.A Pfaller;R.N Jones;G.V Doern;A.C Fluit.
Diagnostic Microbiology and Infectious Disease (1999)
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)
A.C. Gales;R.N. Jones;H.S. Sader.
Clinical Microbiology and Infection (2006)
Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY antimicrobial surveillance program
M.A Pfaller;R.N Jones;G.V Doern;H.S Sader.
Diagnostic Microbiology and Infectious Disease (1999)
Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase
Ana C. Gales;Liana C. Menezes;Suzane Silbert;Hélio S. Sader.
Journal of Antimicrobial Chemotherapy (2003)
Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010).
Ana C. Gales;Mariana Castanheira;Ronald N. Jones;Hélio S. Sader.
Diagnostic Microbiology and Infectious Disease (2012)
Antimicrobial Susceptibility and Epidemiology of a Worldwide Collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001)
Jeffrey T. Kirby;Helio S. Sader;Timothy R. Walsh;Ronald N. Jones.
Journal of Clinical Microbiology (2004)
Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
Jennifer M Streit;Ronald N Jones;Helio S Sader;Thomas R Fritsche.
International Journal of Antimicrobial Agents (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: